B
Bull
Bull · 25%OMI
$7.79
Szenariopreis
$2.800
+0.061 (+2.19%)Zum Schluss
Loading chart…
- High
- 2.820
- Open
- 2.740
- VWAP
- 2.77
- Vol
- 1.27M
- Mkt Cap
- 1.05B
- Low
- 2.690
- Amount
- 3.51M
- EV/EBITDA, TTM
- 6.71
Accendra Health, Inc., formerly Owens & Minor, Inc., is a nationwide pure play home-based care platform. Its Patient Direct segment includes home healthcare divisions (Byram and Apria). The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. It offers a range of products and services for in-home care and delivery, including diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services). Additionally, it supplies a wide range of other home medical equipment, patient care product lines including ostomy, wound care (including negative pressure wound therapy), urology, incontinence and other products and services.
Analyst Ratings (6)
+75.00% upside
Hold
0 Buy
4 Hold
2 Sell
Current: 2.80
Tief
4.00
Durchschnitt
4.90
Hoch
6.00
UBS
Neutral
$4
2025-11-03
UBS
2025-11-03
Kursziel
$4
Neutral
JPMorgan
Underweight
$6
2025-08-27
JPMorgan
2025-08-27
Kursziel
$6
Underweight
UBS
Buy
$7
2025-08-13
UBS
2025-08-13
Kursziel
$7
Buy
Citi
Buy
$7
2025-08-12
Citi
2025-08-12
Kursziel
$7
Buy
BofA
Underperform
—
2025-08-12
BofA
2025-08-12
Kursziel
—
Underperform
Bewertungskennzahlen
The current forward P/E ratio for Accendra Health Inc (OMI) is 3.40, compared to its 5-year average forward P/E of 10.47.
Alphio AI Price Scenarios for OMI
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding OMI
Event-Zeitleiste
News
7.505-07moomooOMI FORGES STRATEGIC ALLIANCE WITH GARNETT COMPONENT SALES TO ENHANCE OEM MARKET PRESENCE
- 4.512-31Newsfilter
Owens & Minor Sells P&HS Segment for $375 Million, Becomes Accendra Health
- 4.512-18Newsfilter
Owens & Minor Renames to Accendra Health, Effective January 2, 2026
8.012-05NASDAQ.COMAre Options Traders Aware of Insights About Owens & Minor Stock That We Are Not?
- 1.012-02Newsfilter
Owens & Minor Management to Attend Two Investor Conferences
OMI FAQ — answered by Alphio AI
Accendra Health, Inc., formerly Owens & Minor, Inc., is a nationwide pure play home-based care platform. Its Patient Direct segment includes home healthcare divisions (Byram and Apria). The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. It offers a range of products and services for in-home care and delivery, including diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services). Additionally, it supplies a wide range of other home medical equipment, patient care product lines including ostomy, wound care (including negative pressure wound therapy), urology, incontinence and other products and services. It operates in the Healthcare sector (WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & S industry).
6 analysts cover OMI: 0 rate it Buy, 4 Hold and 2 Sell. The average price target is 4.90.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.